摘要
目的观察荣心丸治疗扩张型心肌病的临床疗效。方法将150例扩张型心肌病患者随机分为治疗组(78例)和对照组(72例)。治疗组口服荣心丸治疗;对照组常规治疗(极化液、泛葵利酮及强心、利尿、扩血管药等)。对比2组临床效果、心功能变化和病毒学检测情况。结果治疗组临床症状的好转明显高于对照组(P<0.01),心功能改善优于对照组(P<0.05)。2组EVsRNA阴转率差异无统计学意义(P>0.05)。结论在目前对扩张型心肌病无明显特效药物治疗的情况下采用荣心丸治疗为一种可取的药物治疗手段。
Objective To observe the clinical effect of Rongxin pill in dilated cardiomyopathy.Methods 150 cases patients with dilated cardiomyopathy were randomly divided into treatment group( 78 cases) and control group( 72cases).Treatment group was treated by Rongxin pill.The control group accepted conventional treatment( GIK,Pan Kwai risperidone and strong heart,diuretics,vasodilators,etc.).After treatment,compared the clinical effect,cardiac function and virology testing situation of 2 groups.Results Improvement of clinical symptoms of the treatment group was significantly higher than that of control group,the difference was statistically significant( P < 0.01).The improved heart function of observation group was higher than that of control group,the difference was statistically significant( P < 0.05).The EVsRNA conversion rate of 2 groups was no significant difference( P > 0.05).Conclusion At the moment,Under no circumstances specific drug treatment,Rong xin pill in treatment of dilated cardiomyopathy can be a desirable drug treatment.
出处
《临床合理用药杂志》
2016年第16期8-9,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
扩张型心肌病
荣心丸
临床观察
Dilated cardiomyopathy
Rong pill
Clinical observation